And although Boyle doesn’t mention this latest development, umbilical cord blood, taken in the final stage of labor, is now banked by profit-making firms as a potential – though unlikely – source of stem cells for the baby. In biomedicine, a series of legal cases have generated powerful momentum toward the transfer of rights over the body and its component parts from the individual “owner” to corporations and research institutions.